IntegraGen
Private Company
Total funding raised: $48.4M
Overview
IntegraGen is a France-based provider of genomic services and diagnostic solutions, specializing in next-generation sequencing (NGS) and bioinformatics analysis. The company serves academic researchers, clinical and translational research organizations, and biopharma/CROs with a focus on oncology and constitutional genetics. Its business model combines fee-for-service genomics with the distribution of CE-IVD certified software like VarSome Clinical for variant interpretation, positioning it at the intersection of research services and clinical diagnostics.
Technology Platform
Next-generation sequencing (NGS) services combined with proprietary and partnered bioinformatics software for variant interpretation, including the CE-IVD certified VarSome Clinical platform for constitutional genetics and proprietary tools like MERCURY for tumor analysis and GeCo for advanced bioinformatics.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
IntegraGen competes with large, global genomics service providers (e.g., Eurofins, Novogene) and specialized bioinformatics software companies. In the MRD space, it faces competition from established diagnostic companies and startups developing liquid biopsy assays. Its partnership-based distribution model for VarSome Clinical positions it against other clinical variant interpretation platforms like Fabric Genomics, Sophia Genetics, and Qiagen Clinical Insight.